Tuesday, May 19, 2026

Digital Health Week 2026: How Daewoong Pharmaceutical is Revolutionizing Healthcare with 8 Innovative Products

Daewoong Pharmaceutical's Digital Health Week 2026 showcased digital healthcare innovations to 39,753 professionals, highlighting real-world applications.

Wheesung’s Sudden Passing: Cause of Death Under Investigation, Funeral Delayed

Wheesung passed away unexpectedly. His funeral is postponed pending an autopsy to determine the cause of death.

North Korea’s Drone Intrusions: What Experts Say About the 2024 and 2026 Incidents

North Korea's drone incursions are linked to anti-South sentiment, aiming to influence public opinion ahead of the 9th Party Congress.

Tag: Cenobamate

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How SK Life Science is Bridging Communication Gaps in Epilepsy Management

SK Life Science will present findings on epilepsy treatment and patient-provider communication at the 2026 AAN Annual Meeting in Chicago.

Exploring Cenobamate: How SK Biopharmaceuticals’ New Oral Suspension Benefits Adult Epilepsy Patients

SK Biopharmaceuticals submits NDA for Cenobamate oral suspension, enhancing treatment options for epilepsy patients with swallowing difficulties.

SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China

SK Biopharm's epilepsy drug Cenobamate launches in China, marking a key milestone in its global expansion and commercialization strategy.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.